Severance Fee. LICENSEE may elect to end sales of the End Products at its sole discretion with a severance fee (“Severance Fee”) set forth in Exhibit C. If LICENSEE elects to end sales of the End Products, then any other licensing provision benefits for the LICENSEE with respect to the End Products also end at that time. Notwithstanding the foregoing, for a period of 6 months after such election is made, LICENSEE shall be permitted to sell End Products using the Technology in an attempt to sell all finished goods inventories pertaining to the Technology.
Appears in 1 contract
Sources: Intellectual Property License Agreement (Lexaria Bioscience Corp.)
Severance Fee. LICENSEE may elect to end sales of any or all of the End Products at its sole discretion with a severance fee (“Severance Fee”) set forth in Exhibit C. If LICENSEE elects to end sales of any of the End Products, then any other licensing provision benefits for the LICENSEE with respect to the those End Products shall also end at that time. Notwithstanding the foregoing, for a period of 6 months after such election is made, LICENSEE shall be permitted to sell sell-off those End Products using the Technology in an attempt to sell all finished goods inventories pertaining to the Technology.
Appears in 1 contract
Sources: Intellectual Property License Agreement (Lexaria Bioscience Corp.)
Severance Fee. LICENSEE may elect to end sales of all of the End Products in a Product Line, at its sole discretion discretion, with the payment of a severance fee (“Severance Fee”) as set forth in Exhibit C. If LICENSEE elects to end sales of all of the End ProductsProducts in a Product Line, then any other licensing provision benefits for the LICENSEE with respect to the End Products also end at that time. Notwithstanding the foregoing, for a period of 6 months after such election is made, LICENSEE shall be permitted to sell End Products using the Technology in an attempt to sell all finished goods inventories pertaining to the Technology.
Appears in 1 contract
Sources: Intellectual Property License Agreement (Lexaria Bioscience Corp.)